Therapeutic target
Avert deterioration of renal function.
Therapy recommendations
- No effective therapeutic option exists for this form of glomerulonephritis. However, a therapeutic attempt can be made with the platelet aggregation inhibitors acetylsalicylic acid and dipyramidol. The data situation for this is, however, still very little convincing!
- Immunosuppressants also failed to gain acceptance.
- A combination of immunotherapy with regular plasmapheresis prevented the recurrence of membranoproliferative glomerulonephritis for 2 years after kidney transplantation in a single curative trial.
